PCN193 COST-EFFECTIVENESS ANALYSIS OF PEMBROLIZUMAB IN COMBINATION WITH PLATINUM CHEMOTHERAPY AND PEMETREXED FOR PREVIOUSLY UNTREATED PATIENTS WITH METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER IN ENGLAND
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.389
https://www.valueinhealthjournal.com/article/S1098-3015(19)32767-6/fulltext
Title :
PCN193 COST-EFFECTIVENESS ANALYSIS OF PEMBROLIZUMAB IN COMBINATION WITH PLATINUM CHEMOTHERAPY AND PEMETREXED FOR PREVIOUSLY UNTREATED PATIENTS WITH METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER IN ENGLAND
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32767-6&doi=10.1016/j.jval.2019.09.389
First page :
Section Title :
Open access? :
No
Section Order :
10323